-
Je něco špatně v tomto záznamu ?
Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment
D. Darsová, P. Pochop, J. Štěpánková, D. Dotřelová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
28862736
DOI
10.5301/ejo.5001020
Knihovny.cz E-zdroje
- MeSH
- antiflogistika terapeutické užití MeSH
- dítě MeSH
- intermediální uveitida diagnóza farmakoterapie chirurgie MeSH
- lidé MeSH
- mladiství MeSH
- následné studie MeSH
- pooperační období MeSH
- předpověď * MeSH
- recidiva MeSH
- retrospektivní studie MeSH
- vitrektomie metody MeSH
- výsledek terapie MeSH
- zraková ostrost * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: To evaluate the efficacy of pars plana vitrectomy (PPV) as an anti-inflammatory therapy in pediatric recurrent intermediate uveitis. METHODS: A retrospective study evaluated the long-term results of PPV indicated for intermediate uveitis with a mean observation period of 10.3 years (range 7-15.6 years) in 6 children (mean age 8 years, range 6-12 years). Pars plana vitrectomy was performed on 10 eyes in the standard manner and was initiated by vitreous sampling for laboratory examination. Data recorded were perioperative or postoperative vitrectomy complications, anatomic and functional results of PPV, and preoperative and postoperative best-corrected Snellen visual acuity. RESULTS: No perioperative or postoperative complications were observed. Bacteriologic, virologic, mycotic, and cytologic analysis of the vitreous was negative in all tested children. Five eyes were subsequently operated on for posterior subcapsular cataracts. An average preoperative visual acuity of 0.32 improved to an average postoperative visual acuity of 0.8. CONCLUSIONS: In the case of systemic immunosuppressive treatment failure in pediatric uveitis, particularly in eyes with cystoid macular edema, we recommend PPV relatively early.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024691
- 003
- CZ-PrNML
- 005
- 20180713115144.0
- 007
- ta
- 008
- 180709s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5301/ejo.5001020 $2 doi
- 035 __
- $a (PubMed)28862736
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Darsová, Denisa $u Department of Ophthalmology, Second Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague - Czech Republic.
- 245 10
- $a Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment / $c D. Darsová, P. Pochop, J. Štěpánková, D. Dotřelová,
- 520 9_
- $a PURPOSE: To evaluate the efficacy of pars plana vitrectomy (PPV) as an anti-inflammatory therapy in pediatric recurrent intermediate uveitis. METHODS: A retrospective study evaluated the long-term results of PPV indicated for intermediate uveitis with a mean observation period of 10.3 years (range 7-15.6 years) in 6 children (mean age 8 years, range 6-12 years). Pars plana vitrectomy was performed on 10 eyes in the standard manner and was initiated by vitreous sampling for laboratory examination. Data recorded were perioperative or postoperative vitrectomy complications, anatomic and functional results of PPV, and preoperative and postoperative best-corrected Snellen visual acuity. RESULTS: No perioperative or postoperative complications were observed. Bacteriologic, virologic, mycotic, and cytologic analysis of the vitreous was negative in all tested children. Five eyes were subsequently operated on for posterior subcapsular cataracts. An average preoperative visual acuity of 0.32 improved to an average postoperative visual acuity of 0.8. CONCLUSIONS: In the case of systemic immunosuppressive treatment failure in pediatric uveitis, particularly in eyes with cystoid macular edema, we recommend PPV relatively early.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a antiflogistika $x terapeutické užití $7 D000893
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 12
- $a předpověď $7 D005544
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pooperační období $7 D011184
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a intermediální uveitida $x diagnóza $x farmakoterapie $x chirurgie $7 D015867
- 650 12
- $a zraková ostrost $7 D014792
- 650 _2
- $a vitrektomie $x metody $7 D014821
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pochop, Pavel $u Department of Ophthalmology, Second Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague - Czech Republic.
- 700 1_
- $a Štěpánková, Jana $u Department of Ophthalmology, Second Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague - Czech Republic.
- 700 1_
- $a Dotřelová, Dagmar $u Department of Ophthalmology, Second Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague - Czech Republic.
- 773 0_
- $w MED00180219 $t European journal of ophthalmology $x 1724-6016 $g Roč. 28, č. 1 (2018), s. 98-102
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28862736 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180713115438 $b ABA008
- 999 __
- $a ok $b bmc $g 1316822 $s 1021612
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 28 $c 1 $d 98-102 $e 20180219 $i 1724-6016 $m European journal of ophthalmology $n Eur J Ophthalmol $x MED00180219
- LZP __
- $a Pubmed-20180709